GB0312101D0 - Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders - Google Patents

Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders

Info

Publication number
GB0312101D0
GB0312101D0 GB0312101A GB0312101A GB0312101D0 GB 0312101 D0 GB0312101 D0 GB 0312101D0 GB 0312101 A GB0312101 A GB 0312101A GB 0312101 A GB0312101 A GB 0312101A GB 0312101 D0 GB0312101 D0 GB 0312101D0
Authority
GB
United Kingdom
Prior art keywords
pyrazolo
treatment
psychiatric disorders
pyridazine derivatives
pyridazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0312101A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0312101A priority Critical patent/GB0312101D0/en
Publication of GB0312101D0 publication Critical patent/GB0312101D0/en
Ceased legal-status Critical Current

Links

GB0312101A 2003-05-27 2003-05-27 Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders Ceased GB0312101D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0312101A GB0312101D0 (en) 2003-05-27 2003-05-27 Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0312101A GB0312101D0 (en) 2003-05-27 2003-05-27 Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders

Publications (1)

Publication Number Publication Date
GB0312101D0 true GB0312101D0 (en) 2003-07-02

Family

ID=9958799

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0312101A Ceased GB0312101D0 (en) 2003-05-27 2003-05-27 Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders

Country Status (1)

Country Link
GB (1) GB0312101D0 (en)

Similar Documents

Publication Publication Date Title
HK1078858A1 (en) Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
EP1653969A4 (en) Pyrrolo 1,2-b pyridazine derivatives
HK1122808A1 (en) Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders
IL169091A0 (en) Benzazepine derivatives for the treatment of neurological disorders
IL176737A0 (en) Pyrazolo[1,5-a] pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
AU2003286567A1 (en) Methods for the treatment of skin disorders
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
IL160397A0 (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido{1,2-a} pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo {1,2-a} pyrimidin-5 (1h) one derivatives for neurodegenerative disorders
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
HK1084384A1 (en) Pyrazolo [3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
HK1064669A1 (en) Substituted 1-oxy-2,8-diaza-spiro Ä4,5Üdec-2-ene derivatives as medicaments for the treatment of pain.
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
PT1674456E (en) Use of 2-fluoro- 3-ketoesters for preparing 3-fluoro-6,7,8,9-tetrahydro-4-h-pyrimdo[1,2-a]pyrimidin-4-ones
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
SI1603915T1 (en) SUBSTITUTED 8 -PYRIDINYL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE AND 8 -PYRIMIDIN YL-DIHYDROSPIRO- CYCLOALKYL -PYRIMIDO 1,2-a PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES
IL175753A0 (en) PROCESSES FOR THE PREPARATION OF PYRAZOLO [1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
NZ515882A (en) Treatment of serotonin related disorders with 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives
MXPA03008894A (en) Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments.
GB0312101D0 (en) Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders
IL176471A0 (en) Process for the preparation of triazolopyrimidines
WO2004048318A8 (en) Improved process for the preparation of 1,3-substituted indenes
IL172156A0 (en) Use of 2h- [1,3] - oxazinono [3,2 - a] indole derivatives for the treatment of neuropathic pain
GB0326967D0 (en) Use of pyrimidine derivatives for the treatment of psychiatric disorders
HUP0500698A2 (en) Use of an ascomycin for the treatment of blepharitis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)